NAD Recommends Inspired Nutrition Discontinue All Challenged Claims for ‘Ultimate Bio-Fibrin’ Supplement

New York, NY – Aug.  11, 2015 – The National Advertising Division has recommended that Inspired Nutrition, LLC, discontinue all challenged claims for the company’s “Ultimate Bio-Fibrin” Dietary Supplement, including claims that the product offers “new hope for conquering chronic diseases like MRSA  staph, Lyme disease, HIV, Hepatitis, Shingles, Herpes.”

NAD is an investigative unit of the advertising industry’s system of self-regulation and administered by the Council of Better Business Bureaus.

The claims at issue were challenged by the Council for Responsible Nutrition (CRN). CRN files challenges with NAD in an effort to encourage manufacturers of dietary supplements to provide substantiation for their advertising claims to an objective, third-party for review and evaluation and to assure that claims being promoted to consumers are truthful, not misleading and are substantiated with credible scientific evidence.

In response to NAD’s initial inquiry, the advertiser said it would discontinue all claims challenged by CRN, action that NAD found necessary given the lack of evidence in the record.

Challenged claims included:

  • “The Best Enzymes Clinical Studies Show to Dissolve Fibrin Biofilms, Cysts and Internal Scarring!”
  • “New hope for conquering chronic diseases like MRSA staph, Lyme disease, HIV, Hepatitis, Shingles, Herpes.”
  • “(Yes, it dissolves internal scarring as well – kidneys, liver, etc.) This has made our chronic illness protocol extremely effective!”
  • “Our Monolaurin is able to kill all pathogen bacteria and 14 virus … .”
  • “Our Bio-Fibrin ingredients not only dissolve biofilms but they also stimulate the body to increase its production of plasmin to help in the process!”
  • “Serrapeptase…is in wide clinical use throughout Europe and Asia as an anti-inflammatory and fibrin dissolver for 35 years.”
  • “Nattokinase has advantages over the traditional clot-dissolving drugs, such as activase, urokinase, and streptokinase because its effects last longer – eight to ten hours longer!”
  • “Bromelain also prevents the conversion of fibrinogen to the excess fibrin that gives structure to biofilms, cysts and blood clots.”
  • “Papain also increases the body’s ability to produce plasmin.”

The company, in its advertiser’s statement, said it would take “NAD’s recommendations into account in future advertising.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Revolve Group Modify Social Media Posts to Clearly Disclose Material Connection to Influencers

New York, NY – January 29, 2025 – The National Advertising Division recommended Revolve modify influencer posts to clearly and conspicuously disclose the material connections between Revolve and influencers in its product gifting program.

Read the Decision Summary
Decision

National Advertising Division Recommends Bullfrog Modify or Discontinue Certain Comparative Superiority Claims for its Bullfrog Spas

New York, NY – January 29, 2025 – The National Advertising Division recommended that Bullfrog discontinue certain claims promoting the personalization, power, energy efficiency, and durability of its Bullfrog spas as compared to “conventional” hot tubs. 

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Refers Ardyss Earnings and Product Performance Claims to the FTC and Nevada Attorney General’s Office

McLean, VA – January 28, 2025 – The Direct Selling Self-Regulatory Council (DSSRC) referred ArdyssLife to the Federal Trade Commission (FTC) and the Nevada Attorney General’s Office for possible enforcement action after Ardyss failed to confirm intent to comply with DSSRC recommendations to discontinue...

Read the Decision Summary
Decision

National Advertising Division Recommends Olly Discontinue or Modify Certain Claims for its Kids Chillax Product; Olly to Appeal

New York, NY – January 27, 2025 – BBB National Programs’ National Advertising Division recommended that Olly discontinue or modify certain claims concerning its Kids Chillax dietary supplement’s ability to support calm and relaxed moods in children, as well as claims for Olly’s previous formulation of its Kids...

Read the Decision Summary